These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 24878186)
1. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. Kovacs Z; Werner B; Rassi A; Sass JO; Martin-Fiori E; Bernasconi M J Control Release; 2014 Aug; 187():74-82. PubMed ID: 24878186 [TBL] [Abstract][Full Text] [Related]
2. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901 [TBL] [Abstract][Full Text] [Related]
3. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study. Aryal M; Vykhodtseva N; Zhang YZ; McDannold N J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption. Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis. Lin YL; Wu MT; Yang FY J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555 [TBL] [Abstract][Full Text] [Related]
6. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Ting CY; Fan CH; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK Biomaterials; 2012 Jan; 33(2):704-12. PubMed ID: 22019122 [TBL] [Abstract][Full Text] [Related]
7. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. Park J; Zhang Y; Vykhodtseva N; Jolesz FA; McDannold NJ J Control Release; 2012 Aug; 162(1):134-42. PubMed ID: 22709590 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound. Yang FY; Wang HE; Liu RS; Teng MC; Li JJ; Lu M; Wei MC; Wong TT PLoS One; 2012; 7(9):e45468. PubMed ID: 23029030 [TBL] [Abstract][Full Text] [Related]
9. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes. Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650 [TBL] [Abstract][Full Text] [Related]
10. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery. Fan CH; Ting CY; Lin HJ; Wang CH; Liu HL; Yen TC; Yeh CK Biomaterials; 2013 May; 34(14):3706-15. PubMed ID: 23433776 [TBL] [Abstract][Full Text] [Related]
11. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts. Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341 [TBL] [Abstract][Full Text] [Related]
12. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. Aryal M; Vykhodtseva N; Zhang YZ; Park J; McDannold N J Control Release; 2013 Jul; 169(1-2):103-11. PubMed ID: 23603615 [TBL] [Abstract][Full Text] [Related]
13. Focused Ultrasound-Mediated Blood-Brain Barrier Opening Increases Delivery and Efficacy of Etoposide for Glioblastoma Treatment. Wei HJ; Upadhyayula PS; Pouliopoulos AN; Englander ZK; Zhang X; Jan CI; Guo J; Mela A; Zhang Z; Wang TJC; Bruce JN; Canoll PD; Feldstein NA; Zacharoulis S; Konofagou EE; Wu CC Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):539-550. PubMed ID: 33346092 [TBL] [Abstract][Full Text] [Related]
14. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes. Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741 [TBL] [Abstract][Full Text] [Related]
15. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment. Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064 [TBL] [Abstract][Full Text] [Related]
16. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model. Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014 [TBL] [Abstract][Full Text] [Related]
17. Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas. Arrieta VA; Gould A; Kim KS; Habashy KJ; Dmello C; Vázquez-Cervantes GI; Palacín-Aliana I; McManus G; Amidei C; Gomez C; Dhiantravan S; Chen L; Zhang DY; Saganty R; Cholak ME; Pandey S; McCord M; McCortney K; Castro B; Ward R; Muzzio M; Bouchoux G; Desseaux C; Canney M; Carpentier A; Zhang B; Miska JM; Lesniak MS; Horbinski CM; Lukas RV; Stupp R; Lee-Chang C; Sonabend AM Nat Commun; 2024 Jun; 15(1):4698. PubMed ID: 38844770 [TBL] [Abstract][Full Text] [Related]
18. Drug-loaded bubbles with matched focused ultrasound excitation for concurrent blood-brain barrier opening and brain-tumor drug delivery. Fan CH; Ting CY; Chang YC; Wei KC; Liu HL; Yeh CK Acta Biomater; 2015 Mar; 15():89-101. PubMed ID: 25575854 [TBL] [Abstract][Full Text] [Related]
19. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. Tinkov S; Coester C; Serba S; Geis NA; Katus HA; Winter G; Bekeredjian R J Control Release; 2010 Dec; 148(3):368-72. PubMed ID: 20868711 [TBL] [Abstract][Full Text] [Related]
20. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma. Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]